Wolfville, Canada Clinical Trials

A listing of Wolfville, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo (a "dummy" medicine which does not contain any study medicine) - which treatment participants get is decided by an equal chance. The study will …

Novo Nordisk Investigational Site
 (5.7 away) Contact site
  • 0 views
  • 22 Jul, 2021
  • +138 other locations
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is a double-blind, randomized trial with one dose of ALZ-801 compared to placebo.

True North Clinical Research
 (5.7 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +67 other locations
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

ustekinumab
crohn's disease
Viable Clinical Research
 (6.9 away) Contact site
  • 646 views
  • 23 Jul, 2021
  • +991 other locations
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

amyloidosis
alzheimer's disease
mini-mental state examination
True North Clinical Research - New Minas
 (5.7 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +85 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

florbetapir
alzheimer's disease
positron emission tomography
flortaucipir
mini-mental state examination
True North Clinical Research
 (5.7 away) Contact site
  • 79 views
  • 18 Jul, 2021
  • +389 other locations
Psoriasis Longitudinal Assessment and Registry

The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient and disease characteristics, including patient-reported …

brodalumab
infliximab
guselkumab
psoriasis
ustekinumab
Michael Shaffelburg M.D.
 (6.7 away) Contact site
  • 4031 views
  • 17 Jul, 2021
  • +491 other locations